Alkermes is a biotechnology company focused on neuroscience, developing medicines for complex and difficult-to-treat psychiatric and neurological disorders. Its therapeutic areas include addiction, serious mental illness, and sleep disorders. The company's approach is built on deep neuroscience expertise and an integrated research strategy.
The company maintains a portfolio of marketed medicines for these conditions, alongside a pipeline of investigational candidates. It operates within the pharmaceutical development and biotech sectors, with a specialized commercial infrastructure to support its products.
Alkermes describes its culture as patient-inspired, with collaboration at its core. The company states that it values every person and respects each voice, and has been recognized as an employer of choice in the biotech industry. Core values guide its operations, with an emphasis on working with urgency.
